U.S. Drugmaker Eli Lilly To Pause Antibody Trial Over Safety Concerns
U.S. health regulators have paused Eli Lilly’s trial of an antibody treatment for COVID-19 over potential safety concerns. It was confirmed on Tuesday that regulators paused enrollment in the leading late-stage trial of monoclonal antibody treatment for